Literature DB >> 23952895

Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence.

Kelly S Barth1, Megan Moran-Santa Maria, Katie Lawson, Stephanie Shaftman, Kathleen T Brady, Sudie E Back.   

Abstract

BACKGROUND AND OBJECTIVES: Patients with prescription opioid use disorders and co-occurring pain present a formidable challenge for healthcare providers, and little is known about patients with this dual diagnosis. This study examined the prevalence of pain and motives for use among individuals with prescription opioid dependence.
METHODS: Participants (N = 127) included 86 non-treatment seeking individuals with current prescription opioid dependence and 41 healthy controls. They were administered a battery of assessments to evaluate pain and substance use.
RESULTS: Participants with prescription opioid dependence were significantly more likely than controls to report current pain (62.2 vs. 12.2%), as well as higher levels of pain interference and severity. The most common source of prescription opioids was a physician (91.3%) and the most common motive for using prescription opioids, initially and currently, was to relieve pain (70.3% and 81.0%, respectively). Motivation for subsequent non-medical use of prescription opioids included to get high (73.8%), to increase energy (71.0%), to decrease anxiety (51.2%), and to improve sleep (35.7%).
CONCLUSION: Pain is a significant comorbidity and motivator for the non-medical use of prescription opioids. Provider and patient education regarding the safe use of prescription opioids, as well as interventions targeting prescription opioid dependence, are needed.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2013        PMID: 23952895      PMCID: PMC3748383          DOI: 10.1111/j.1521-0391.2013.12038.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  42 in total

1.  Motives, diversion and routes of administration associated with nonmedical use of prescription opioids.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd; Christian J Teter
Journal:  Addict Behav       Date:  2006-07-13       Impact factor: 3.913

2.  Prescription opioids, overdose deaths, and physician responsibility.

Authors:  A Thomas McLellan; Barbara Turner
Journal:  JAMA       Date:  2008-12-10       Impact factor: 56.272

3.  Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index.

Authors:  John S Cacciola; Arthur I Alterman; A Thomas McLellan; Yi-Ting Lin; Kevin G Lynch
Journal:  Drug Alcohol Depend       Date:  2006-10-11       Impact factor: 4.492

4.  Chronic pain in the Republic of Ireland--community prevalence, psychosocial profile and predictors of pain-related disability: results from the Prevalence, Impact and Cost of Chronic Pain (PRIME) study, part 1.

Authors:  Miriam N Raftery; Kiran Sarma; Andrew W Murphy; Davida De la Harpe; Charles Normand; Brian E McGuire
Journal:  Pain       Date:  2011-03-29       Impact factor: 6.961

Review 5.  Treatment of chronic pain by long-acting opioids and the effects on sleep.

Authors:  Kyriaki Mystakidou; A John Clark; Jürgen Fischer; Annette Lam; Karin Pappert; Ute Richarz
Journal:  Pain Pract       Date:  2010-09-20       Impact factor: 3.183

6.  Motivations for non-medical prescription drug use: a mixed methods analysis.

Authors:  Khary K Rigg; Gladys E Ibañez
Journal:  J Subst Abuse Treat       Date:  2010-07-29

7.  Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment.

Authors:  Jodie A Trafton; Elizabeth M Oliva; Doyanne A Horst; Jared D Minkel; Keith Humphreys
Journal:  Drug Alcohol Depend       Date:  2004-01-07       Impact factor: 4.492

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond.

Authors:  Sean Esteban McCabe; Carol J Boyd; James A Cranford; Christian J Teter
Journal:  Arch Pediatr Adolesc Med       Date:  2009-08

10.  Persistent pain is associated with substance use after detoxification: a prospective cohort analysis.

Authors:  Mary Jo Larson; Michael Paasche-Orlow; Debbie M Cheng; Christine Lloyd-Travaglini; Richard Saitz; Jeffrey H Samet
Journal:  Addiction       Date:  2007-05       Impact factor: 6.526

View more
  22 in total

1.  Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.

Authors:  Kelly E Dunn; Patrick H Finan; D Andrew Tompkins; Eric C Strain
Journal:  Addict Behav       Date:  2017-07-14       Impact factor: 3.913

Review 2.  Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development.

Authors:  Colleen A Hanlon; Logan T Dowdle; J Scott Henderson
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 3.  Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.

Authors:  Ryan Vandrey; Kimberly A Babson; Evan S Herrmann; Marcel O Bonn-Miller
Journal:  Int Rev Psychiatry       Date:  2014-04

4.  Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy.

Authors:  Brandon S Bentzley; Kelly S Barth; Sudie E Back; Garrett Aronson; Sarah W Book
Journal:  J Subst Abuse Treat       Date:  2015-04-07

Review 5.  Prescription drug abuse: from epidemiology to public policy.

Authors:  R Kathryn McHugh; Suzanne Nielsen; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2014-08-28

6.  Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.

Authors:  Scott P Stumbo; Bobbi Jo H Yarborough; Dennis McCarty; Constance Weisner; Carla A Green
Journal:  J Subst Abuse Treat       Date:  2016-11-15

7.  Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Margaret L Griffin; R Kathryn McHugh; Deborah Haller; Petra Jacobs; John Gardin; Dan Fischer; Kristen D Rosen
Journal:  J Subst Abuse Treat       Date:  2014-04-04

8.  Laboratory-induced cue reactivity among individuals with prescription opioid dependence.

Authors:  Sudie E Back; Daniel F Gros; Jenna L McCauley; Julianne C Flanagan; Elizabeth Cox; Kelly S Barth; Kathleen T Brady
Journal:  Addict Behav       Date:  2014-04-12       Impact factor: 3.913

Review 9.  Drug effects on responses to emotional facial expressions: recent findings.

Authors:  Melissa A Miller; Anya K Bershad; Harriet de Wit
Journal:  Behav Pharmacol       Date:  2015-09       Impact factor: 2.293

10.  Pain management perceptions among prescription opioid dependent individuals.

Authors:  Jenna L McCauley; Mary Ashley Mercer; Kelly S Barth; Kathleen T Brady; Sudie E Back
Journal:  Drug Alcohol Depend       Date:  2014-06-25       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.